Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Uy

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
The Chicago Medical School Quarterly|January 1, 1970
Basic cytogeneticsE Uy, E Krmpotic
The Chicago Medical School Quarterly|January 1, 1970
Sex chromosome abnormalitiesE Krmpotic, E Uy, K Szego
The Chicago Medical School Quarterly|January 1, 1970
Autosomal chromosome abnormalitiesE Krmpotic, E Uy, D Meeker
Journal of General Internal Medicine|June 25, 2015
Facial Swelling and Rash Following Tooth ExtractionHyungjoo Ham, Christopher E Uy, Dawn DeWitt
Practical Neurology|June 10, 2021
Autoimmune encephalitis: clinical spectrum and managementChristopher E Uy, Sophie Binks, Sarosh R Irani
BMJ Case Reports|January 9, 2015
Epidural abscess and feculent meningitis secondary to stercoral ulcer ruptureChristopher E Uy, Shi Yuan Jiang, Melanie C M Murray
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 22, 2020
Reperfusion Therapy for Acute Stroke in Pregnant and Post-Partum Women: A Canadian SurveyChristopher E Uy, Stéphanie Gosselin-Lefebvre, Adam M Book, et al.
Experimental Physiology|October 9, 2012
Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese miceK-Lynn N Hogh, Christopher E Uy, Ali Asadi, et al.
Endocrinology|July 23, 2014
Overexpression of PPARγ specifically in pancreatic β-cells exacerbates obesity-induced glucose intolerance, reduces β-cell mass, and alters islet lipid metabolism in male miceK-Lynn N Hogh, Michael N Craig, Christopher E Uy, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 9, 2026
A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient CohortDavid J Hunt, Nathan Y Chu, Donna Kuipers, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
The Chicago Medical School Quarterly|January 1, 1970
Basic cytogeneticsE Uy, E Krmpotic
The Chicago Medical School Quarterly|January 1, 1970
Sex chromosome abnormalitiesE Krmpotic, E Uy, K Szego
The Chicago Medical School Quarterly|January 1, 1970
Autosomal chromosome abnormalitiesE Krmpotic, E Uy, D Meeker
Journal of General Internal Medicine|June 25, 2015
Facial Swelling and Rash Following Tooth ExtractionHyungjoo Ham, Christopher E Uy, Dawn DeWitt
Practical Neurology|June 10, 2021
Autoimmune encephalitis: clinical spectrum and managementChristopher E Uy, Sophie Binks, Sarosh R Irani
BMJ Case Reports|January 9, 2015
Epidural abscess and feculent meningitis secondary to stercoral ulcer ruptureChristopher E Uy, Shi Yuan Jiang, Melanie C M Murray
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|September 22, 2020
Reperfusion Therapy for Acute Stroke in Pregnant and Post-Partum Women: A Canadian SurveyChristopher E Uy, Stéphanie Gosselin-Lefebvre, Adam M Book, et al.
Experimental Physiology|October 9, 2012
Overexpression of peroxisome proliferator-activated receptor α in pancreatic β-cells improves glucose tolerance in diet-induced obese miceK-Lynn N Hogh, Christopher E Uy, Ali Asadi, et al.
Endocrinology|July 23, 2014
Overexpression of PPARγ specifically in pancreatic β-cells exacerbates obesity-induced glucose intolerance, reduces β-cell mass, and alters islet lipid metabolism in male miceK-Lynn N Hogh, Michael N Craig, Christopher E Uy, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|January 9, 2026
A Retrospective Evaluation of Ocrelizumab and Rituximab Discontinuation in a Real-World Patient CohortDavid J Hunt, Nathan Y Chu, Donna Kuipers, et al.
Pageof 2